APA (7th ed.) Citation

T, O., WR, L., SH, K., & KD, S. (2026). Apolipoprotein B/A1 Ratio Improves Discrimination of Severe Atherosclerosis Beyond Conventional Lipid Markers in High-Risk Statin-Naive Patients. Journal of clinical medicine, 15(14), . https://doi.org/10.3390/jcm15145598

Chicago Style (17th ed.) Citation

T, Ok, Lee WR, Kim SH, and Seo KD. "Apolipoprotein B/A1 Ratio Improves Discrimination of Severe Atherosclerosis Beyond Conventional Lipid Markers in High-Risk Statin-Naive Patients." Journal of Clinical Medicine 15, no. 14 (2026). https://doi.org/10.3390/jcm15145598.

MLA (9th ed.) Citation

T, Ok, et al. "Apolipoprotein B/A1 Ratio Improves Discrimination of Severe Atherosclerosis Beyond Conventional Lipid Markers in High-Risk Statin-Naive Patients." Journal of Clinical Medicine, vol. 15, no. 14, 2026, https://doi.org/10.3390/jcm15145598.